CHV (Catalyst Health Ventures) invests in transformative MedTech companies that are addressing global unmet healthcare needs and have the potential to become the new standard of care. Our thesis is exclusively focused on innovative early stage therapeutic devices, diagnostics and digital health solutions that significantly improve outcomes for patients, providers and payers.
Location: United States, Massachusetts, Boston
Employees: 1-10
Founded date: 2008
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| 12.09.2024 | Venova Med... | venovamedical.com | - | - |
| 16.12.2022 | Rejoni | rejoni.com | $25M | - |
| - | PanTher Th... | panthertx.com | $14.2M | United Sta... |
| - | Brixton Bi... | brixtonbio.com | $33M | United Sta... |
| - | Conformal ... | conformalmedical.com | $44M | - |
| - | Avive Solu... | avive.life | $86M | United Sta... |
| - | Aria CV, I... | ariacv.com | $31M | United Sta... |
| - | Epitel | epitel.com | $12.5M | United Sta... |
| - | Cruzar Med... | cruzarmed.com | - | - |
| - | AtaCor Med... | atacor.com | $61.8M | United Sta... |
Show more
Mentions in press and media 4
| Date | Title | Description |
| 11.08.2021 | Meet Josh Phillips and Darshana Zaveri, managing partners at Catalyst Health Ventures | CHV invests exclusively in seed, Series A and Series B companies in the medtech space Venture capital used to be a cottage industry, with very few investing in tomorrow's products and services. Oh, how times have changed! While there are mo... |
| 28.07.2016 | Catalyst Health Ventures Joins $12M Series B for nVision | nVision Medical Corp, a clinical-stage, privately-held medical device company, today announced a $12 million Series B financing. The proceeds will be used to support further product development, clinical studies, and regulatory submissions ... |
| 28.07.2016 | Catalyst Health Ventures Joins $12M Series B for nVision | nVision Medical Corp, a clinical-stage, privately-held medical device company, today announced a $12 million Series B financing. The proceeds will be used to support further product development, clinical studies, and regulatory submissions ... |
| - | Wow of the week: 3-D scanner maps ear canal to improve hearing aid development (video) | In a move to disrupt the hearing industry, a medical device company has launched a handheld 3-D scanner to map the inner ear to improve the quality of hearing aids. It’s also offering the platform to any hearing aid maker that wants it. The... |